Major histocompatibility complex-I (MHC-I) molecules bind to peptides expressed by cells and present antigen information on the cell surface, enabling immune cells, including CD8+ T cells, to identify abnormal protein-synthesizing pathological cells, such as cancer cells expressing mutant proteins [3,4]. The gene discussed is CD8A; the disease is cancer.